Multi-modal shape memory polymers

US9308293B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9308293-B2
Application numberUS-201514615322-A
CountryUS
Kind codeB2
Filing dateFeb 5, 2015
Priority dateApr 19, 2007
Publication dateApr 12, 2016
Grant dateApr 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to a multi-modal shape memory polymer material comprising a blend or at least one polymer component having a first molecular weight and at least a second polymer component having a second molecular weight that is less than the first component.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for making a bone implant comprising: preparing a bone implant comprising a multi-modal shape memory polymer material comprising a blend of at least a first polymer component having a first molecular weight and at least a second polymer component having a second molecular weight that is less than the first component, the first polymer component and the second polymer component being miscible, at least one of the first or second polymer components being non-resorbable, wherein if a bone implant so prepared is provided with energy and heated to a temperature higher than the glass transition temperature of the polymer, but lower than its melting temperature, the implant material will flow, and if inserted into bone, will flow into pores of the bone thereby implanting the implant into the bone. 2. The method of claim 1 , wherein the first molecular weight is in excess of about 50,000 Daltons and the second molecular weight is up to about 20,000 Daltons. 3. The method of claim 1 , wherein the first molecular weight is between about 50,000 and about 1,000,000 Daltons and the second molecular weight is between about 2,000 and about 30,000 Daltons. 4. The method of claim 1 , wherein the first polymer component comprises about 80% of the polymer blend and the second polymer component comprises about 20% of the polymer blend. 5. The method of claim 2 , wherein the first polymer component comprises about 80% of the polymer blend and the second polymer component comprises about 20% of the polymer blend. 6. The method of claim 1 , wherein the multi-modal shape memory polymer is bimodal, and the first polymer component and the second polymer component are both non-resorbable. 7. The method of claim 1 , wherein the implant further comprises reinforced polymeric material comprising a composite or matrix including reinforcing material or phases selected from the group consisting of glass fibers, carbon fibers, polymeric fibers, ceramic particulates, rods, platelets, and combinations thereof. 8. The method of claim 1 , wherein at least one or both of the at least one polymer component and the second polymer component includes a component selected from the group consisting of polyacrylates, polymethyl methacrylate polymers or copolymers thereof, polybutyl methacrylate polymers or copolymers thereof, polybutyl methacrylate-co-polymethyl methacrylate copolymers, polystyrene copolymers, and combinations thereof. 9. The method of claim 1 , wherein the article comprises active agents selected from the group consisting of bone morphogenic proteins, antibiotics, anti-inflammatories, angiogenic factors, osteogenic factors, monobutyrin, thrombin, modified proteins, platelet rich plasma, platelet rich solution, platelet poor plasma, platelet poor solution, bone marrow aspirate, and combinations thereof, and the active agent is incorporated into the polymeric shape memory material to be released during the relaxation and/or degradation of the polymer material. 10. A method of manufacturing a bone implant that, if implanted and exposed to energy and heat, flows into surrounding bone enhancing implantation comprising: creating a desired bone implant comprising a multi-modal shape memory polymer material comprising a blend of at least a first polymer component having a first molecular weight and at least a second polymer component having a second molecular weight that is less than the first component, the first polymer component and the second polymer component being miscible, and at least one of the first or second polymer components being non-resorbable, wherein if the implant is inserted into bone and provided with energy and heat to a temperature higher than the glass transition temperature of the polymer, but lower than its melting temperature, the material flows into pores of the bone thereby enhancing implantation of the implant into the bone. 11. The method of claim 10 , wherein the first molecular weight is in excess of about 50,000 Daltons and the second molecular weight is up to about 20,000 Daltons. 12. The method of claim 10 , wherein the first molecular weight is between about 50,000 and about 1,000,000 Daltons and the second molecular weight is between about 2,000 and about 30,000 Daltons. 13. The method of claim 10 , wherein the first polymer component comprises about 80% of the polymer blend and the second polymer component comprises about 20% of the polymer blend. 14. The method of claim 10 , wherein the multi-modal shape memory polymer is bimodal, and the first polymer component and the second polymer component are both non-resorbable. 15. The method of claim 10 , wherein the implant is porous. 16. The method of claim 10 , wherein the implant further comprises reinforced polymeric material comprising a composite or matrix including reinforcing material or phases selected from the group consisting of glass fibers, carbon fibers, polymeric fibers, ceramic particulates, rods, platelets, and combinations thereof. 17. The method of claim 10 , wherein at least one or both of the at least one polymer component and the second polymer component includes a component selected from the group consisting of polyacrylates, polymethyl methacrylate polymers or copolymers thereof, polybutyl methacrylate polymers or copolymers thereof, polybutyl methacrylate-co-polymethyl methacrylate copolymers, polystyrene copolymers, and combinations thereof. 18. The method of claim 10 , wherein the article comprises active agents selected from the group consisting of bone morphogenic proteins, antibiotics, anti-inflammatories, angiogenic factors, osteogenic factors, monobutyrin, thrombin, modified proteins, platelet rich plasma, platelet rich solution, platelet poor plasma, platelet poor solution, bone marrow aspirate, and combinations thereof, and are incorporated into the polymeric shape memory material to be released during the relaxation and/or degradation of the polymer material. 19. A method of implanting an article into bone comprising: implanting a bone implant article into a bone, the article comprising a multi-modal shape memory polymer material comprising a blend of at least a first polymer component having a first molecular weight and at least a second polymer component having a second molecular weight that is less than the first component, the first polymer component and the second polymer component being miscible, at least one of the first or second polymer components being non-resorbable, and wherein upon implanting the article into bone and providing the article with energy and heating to a temperature higher than the glass transition temperature of the polymer, but lower than its melting temperature, the material flows into pores of the bone thereby implanting the article into the bone. 20. The method of claim 19 , wherein at least one or both of the at least one polymer component and the second polymer component includes a component selected from the group consisting of polyacrylates, polymethyl methacrylate polymers or copolymers thereof, polybutyl methacrylate polymers or copolymers thereof, polybutyl methacrylate-co-polymethyl methacrylate copolymers, polystyrene copolymers, and combinations thereof. 21. The method of claim 19 , wherein the article comprises active agents selected from the group consisting of bone morphogenic proteins, antibiotics, anti-inflammatories, angiogenic factors, osteogenic factors, monobutyrin, thrombin, modified proteins, platelet rich plasma, platelet rich solution, platelet poor

Assignees

Inventors

Classifications

  • A61L31/04Primary

    Macromolecular materials · CPC title

  • Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

  • Polyesters or polycarbonates according to C08L67/00 - C08L69/00; Derivatives thereof · CPC title

  • A61L27/26Primary

    Mixtures of macromolecular compounds · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9308293B2 cover?
The present disclosure relates to a multi-modal shape memory polymer material comprising a blend or at least one polymer component having a first molecular weight and at least a second polymer component having a second molecular weight that is less than the first component.
Who is the assignee on this patent?
Smith & Nephew Inc
What technology area does this patent fall under?
Primary CPC classification A61L31/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).